Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Nov
22
2019
Limitations on Pre-Employment Testing for Marijuana Epstein Becker & Green, P.C.
Feb
2
2016
FDA Recommends Medical Device Manufacturers Implement a Comprehensive Cybersecurity Risk Management Program in Accordance with NIST Standards Epstein Becker & Green, P.C.
Jul
13
2023
The 2023 DOJ Health Care Fraud Enforcement (f/k/a “Takedown”): Big Dollars or Clever Packaging? Epstein Becker & Green, P.C.
Mar
19
2020
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic Epstein Becker & Green, P.C.
Apr
28
2020
Face or Fingerprint? The DEA Revisits Biometric Identifiers for e-Prescribing Controlled Substances Epstein Becker & Green, P.C.
Nov
29
2023
In Genesis Case, South Carolina District Court Scraps HRSA Interpretation of “Patient” Under 340B Statute Epstein Becker & Green, P.C.
Dec
5
2023
Unpacking Averages: Analyzing FDA Device-Related Citizens Petitions by Topic Epstein Becker & Green, P.C.
Mar
5
2024
Unpacking Averages: Analyzing FDA’s Performance in Finalizing Guidance Documents Epstein Becker & Green, P.C.
Oct
23
2018
CMS Unveils Proposed Rule Regarding Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products Epstein Becker & Green, P.C.
Dec
18
2018
Mixed Results for Employers on Marijuana – Two Federal Courts Refuse to Find State Marijuana Laws Preempted by Federal Law Epstein Becker & Green, P.C.
Aug
29
2019
Will the Growing Acceptance of Cannabis Send Drug-Screening Policies Up in Smoke? Epstein Becker & Green, P.C.
Mar
24
2020
Medical Marijuana Deemed “Essential” During COVID-19 Pandemic Epstein Becker & Green, P.C.
Oct
24
2023
DEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 2024 Epstein Becker & Green, P.C.
Jan
5
2024
Hospital and MA Plan Considerations for CMS Final Rule to Remedy 340B Drug Payment Policy Epstein Becker & Green, P.C.
Feb
27
2024
FDA Releases Updated Directory on Select Dietary Supplement Ingredients Epstein Becker & Green, P.C.
Jan
10
2017
New Federal and State Initiatives Seek to Combat Antimicrobial Resistance Epstein Becker & Green, P.C.
Mar
20
2024
FDA Releases Draft Guidance on New Dietary Ingredient Notification Procedures, Timelines Epstein Becker & Green, P.C.
May
14
2024
Litigating Nutrition: Class Action Battles Over Dietary Supplements [Podcast, Video] Epstein Becker & Green, P.C.
Jun
7
2017
Growing Questions About Employee Medical Marijuana Use Leave Employers in a Haze Epstein Becker & Green, P.C.
Aug
17
2021
Marijuana Legalization Rundown: New Legislation Across Several States Epstein Becker & Green, P.C.
Feb
13
2019
CBD “Edibles” Face Opposition from States, FDA Epstein Becker & Green, P.C.
Feb
26
2019
FDA Finalizes Two Guidance Documents Regarding Regenerative Medicine Therapies Epstein Becker & Green, P.C.
Sep
6
2022
Unpacking Averages: Assessing FDA’s Focus on Enforcing 510(K) Requirements on Imports Epstein Becker & Green, P.C.
Mar
10
2015
3-D Printing Guidance Only a B-List Priority for FDA Epstein Becker & Green, P.C.
Jul
18
2019
Hawaii Decriminalizes Possession of Small Amounts of Marijuana Epstein Becker & Green, P.C.
Feb
1
2023
Unpacking Averages: Using NLP to Assess FDA’s Compliance with Notice and Comment in Guidance Development Epstein Becker & Green, P.C.
Nov
3
2023
FDA LDT Webinar Serves as a Reminder to Industry to Submit Comments on the Proposed Rule Epstein Becker & Green, P.C.
Apr
30
2024
It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs) as Medical Devices Has Arrived Epstein Becker & Green, P.C.
May
8
2024
Unpacking Averages: Assessing the Products Included in FDA's Voluntary Malfunction Summary Reporting Program Epstein Becker & Green, P.C.
Aug
18
2017
FDA Makes Moves to Advance Digital Health Epstein Becker & Green, P.C.
Aug
28
2017
NYC OATH Decision Finds for Medical Marijuana User Epstein Becker & Green, P.C.
Sep
18
2017
Federal Laws Do Not Preempt Connecticut Law Providing Employment Protections to Medical Marijuana Users Epstein Becker & Green, P.C.
Sep
14
2021
Marijuana Legalization Rundown: Recent Judicial Decisions Epstein Becker & Green, P.C.
Oct
1
2018
FDA Seeks Civil Monetary Penalties Measures to Enforce Compliance with ClinicalTrials.org Requirements Epstein Becker & Green, P.C.
Oct
29
2018
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins